The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Rispone 4 mg film-coated tablets



Rowex LtdPA0711/106/009

Main Information

Trade NameRispone 4 mg film-coated tablets
Active SubstancesRisperidone
Dosage FormFilm-coated tablet
Licence HolderRowex Ltd
Licence NumberPA0711/106/009

Group Information

ATC CodeN05AX Other antipsychotics
N05AX08 risperidone

Status

License statusWithdrawn
Withdrawn Date01/11/2023
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0012-008-003
Interchangeable List DocumentPDF of Interchangeable List
« Back